Comprehensive assessment of T-cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high-throughput sequencing

Pediatric Diabetes
Juanjuan ZhangGuang Ning

Abstract

We aimed to investigate T-cell receptor (TCR) repertoires in type 1 diabetes (T1D) patients receiving autologous hematopoietic stem cell transplantation (AHSCT) treatment. High-throughput deep TCR beta (TCRB) chain sequencing was performed to assess millions of individual TCRs in five T1D patients receiving AHSCT treatment and another five patients receiving insulin treatment during 12 months of follow-up. No significant changes in TCRB sequence reads, complementarity-determining region 3 (CDR3) sequences, or the usage of TCRB VJ gene-segments were observed at 12 months after AHSCT. Compared with the baseline, the usage of TCRB VJ gene-segments at 12 months decreased in the insulin treatment group (1836.4 ± 437.7 vs 2763.6 ± 390.6, P = 0.015), and the change rates were larger than those undergoing AHSCT (-0.62 ± 0.16 vs 0.06 ± 0.45, P = 0.002). Changes in the TCR repertoire were smaller after AHSCT than those with insulin treatment (P = 2.2*10-32 ). TCRBV 7-7/TCRBJ 2-5 was depleted after AHSCT while expanded with insulin treatment. TCRBV 12-4, TCRBV 10-3, TCRBV 12-3/TCRBJ 1-2 were expanded after AHSCT while ablated with insulin treatment. We found that AHSCT is safe without reduction in the diversity of TCR repertoires and TCR ...Continue Reading

References

Nov 5, 1999·Science·T P ArstilaP Kourilsky
Jun 3, 2005·Nature·Megan Sykes, Boris Nikolic
Dec 29, 2006·Diabetes Care·UNKNOWN American Diabetes Association
Apr 12, 2007·JAMA : the Journal of the American Medical Association·Júlio C VoltarelliRichard K Burt
Oct 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paolo MontiEzio Bonifacio
May 6, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Elsa LaughlinGerald Nepom
May 1, 2010·Nature·Jeffrey A BluestoneGeorge Eisenbarth
Sep 2, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·George DuZheng W Chen
Feb 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eva Codina-BusquetaMercè Martí
Mar 5, 2011·EMBO Molecular Medicine·Ilgar Z MamedovYuri B Lebedev
Aug 25, 2011·Endocrine Reviews·Paolo FiorinaNicholas Zavazava
Feb 18, 2014·The Journal of Clinical Investigation·Paolo A MuraroLaurence A Turka
Feb 15, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne EugsterEzio Bonifacio
Mar 16, 2016·Nature Communications·Isabelle SerrCarolin Daniel
Dec 7, 2016·Diabetes·Aaron W MichelsMaki Nakayama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.